US6046177A
(en)
*
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
AU775037B2
(en)
*
|
1998-12-09 |
2004-07-15 |
Eli Lilly And Company |
Pellet implant system
|
DE59804823D1
(de)
*
|
1997-09-25 |
2002-08-22 |
Bayer Ag |
Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
|
KR100569763B1
(ko)
*
|
1997-10-03 |
2006-04-11 |
워너-램버트 캄파니 엘엘씨 |
니트로글리세린 압축 정제 및 그의 제조 방법
|
US6099865A
(en)
*
|
1998-07-08 |
2000-08-08 |
Fmc Corporation |
Croscarmellose taste masking
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
UA67802C2
(uk)
*
|
1998-10-23 |
2004-07-15 |
Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. |
Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6245352B1
(en)
*
|
1999-04-27 |
2001-06-12 |
Eli Lilly And Company |
Pharmaceutical formulation
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
EP1207852A4
(de)
*
|
1999-09-02 |
2009-11-11 |
Nostrum Pharmaceuticals Inc |
Orale darreichung mit gesteuerter freisetzung zur oralen verabreichung
|
DE19941769A1
(de)
*
|
1999-09-02 |
2001-03-08 |
Beiersdorf Ag |
Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
|
US6346231B1
(en)
*
|
1999-10-06 |
2002-02-12 |
Joar Opheim |
Flavored gelatin capsule and method of manufacture
|
US6294013B1
(en)
*
|
1999-12-08 |
2001-09-25 |
Sun Chemical Corporation |
Polysaccharide pigment dispersions
|
CA2726789A1
(en)
*
|
2000-02-05 |
2001-11-08 |
Theravance, Inc. |
Cyclodextrin containing glycopeptide antibiotic compositions
|
US20030148996A1
(en)
*
|
2000-03-31 |
2003-08-07 |
Joseph Rubinfeld |
Camptothecin complexes
|
DE60128215T2
(de)
*
|
2000-04-20 |
2008-01-10 |
Novartis Ag |
Beschichtungszusammensetzung zur geschmacksmaskierung
|
US6953586B1
(en)
|
2000-06-08 |
2005-10-11 |
Ivy Animal Health, Inc. |
Growth promoting pharmaceutical implant
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
PE20020578A1
(es)
|
2000-10-10 |
2002-08-14 |
Upjohn Co |
Una composicion de antibiotico topico para el tratamiento de infecciones oculares
|
US6566556B2
(en)
*
|
2000-12-19 |
2003-05-20 |
Nippon Shokubai Co., Ltd. |
Method for production of alkanolamine and apparatus therefor
|
AU2002241823A1
(en)
*
|
2001-01-11 |
2002-07-24 |
Eastman Chemical Company |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
IN190699B
(de)
*
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
US7034013B2
(en)
*
|
2001-03-20 |
2006-04-25 |
Cydex, Inc. |
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
|
DE10114245A1
(de)
*
|
2001-03-22 |
2002-10-02 |
Heraeus Kulzer Gmbh & Co Kg |
Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
|
DE10114364A1
(de)
*
|
2001-03-22 |
2002-10-02 |
Heraeus Kulzer Gmbh & Co Kg |
Verfahren zur Herstellung von antibiotischen Kompositen
|
EP1269994A3
(de)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
|
WO2003028718A1
(en)
*
|
2001-10-01 |
2003-04-10 |
Smithkline Beecham Corporation |
Novel formulations of carvedilol
|
US7141540B2
(en)
*
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
EP1461044A4
(de)
*
|
2001-12-03 |
2007-06-13 |
Novacea Inc |
Pharmazeutische zusammensetzungen mit aktiven vitamin-d-verbindungen
|
US6881726B2
(en)
*
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
CA2473991C
(en)
|
2002-02-01 |
2009-09-15 |
Pfizer Products Inc. |
Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
|
JP2005521690A
(ja)
*
|
2002-02-22 |
2005-07-21 |
ファルマシア・コーポレーション |
ゴム系を含む眼科用製剤
|
US20040019012A1
(en)
*
|
2002-02-22 |
2004-01-29 |
Singh Satish K. |
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
|
US6869939B2
(en)
*
|
2002-05-04 |
2005-03-22 |
Cydex, Inc. |
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
|
US20040034099A1
(en)
*
|
2002-06-27 |
2004-02-19 |
Ramsey Beverly J. |
Pharmaceutical composition
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
IL152573A
(en)
*
|
2002-10-31 |
2009-11-18 |
Transpharma Medical Ltd |
A system for the transmission through the skin of a medical preparation against vomiting and nausea
|
IL152575A
(en)
*
|
2002-10-31 |
2008-12-29 |
Transpharma Medical Ltd |
A skin-to-skin transmission system of water-insoluble drugs
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20050026849A1
(en)
*
|
2003-03-28 |
2005-02-03 |
Singh Chandra U. |
Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
US20070020196A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
US20070020299A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
EP1730751B1
(de)
*
|
2004-03-12 |
2009-10-21 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
Magnetoresistives medium
|
US8198270B2
(en)
*
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
CN102174076A
(zh)
|
2004-04-15 |
2011-09-07 |
普罗特奥里克斯公司 |
用于抑制蛋白酶体酶的化合物
|
AU2015255259B2
(en)
*
|
2004-04-23 |
2017-07-27 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
SI2708225T1
(sl)
*
|
2004-04-23 |
2019-05-31 |
Cydex Pharmaceuticals, Inc. |
Formulacija DPI, ki vsebuje sulfoalkil eter ciklodekstrin
|
AU2013201437B2
(en)
*
|
2004-04-23 |
2015-09-03 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
DK2030981T3
(da)
*
|
2004-05-10 |
2014-10-13 |
Onyx Therapeutics Inc |
Forbindelser til proteasom-enzymhæmning
|
US20050265955A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
US20080075784A1
(en)
*
|
2004-07-22 |
2008-03-27 |
Pfizer Inc. |
Taste Making Formulation Comprising The Drug In A Dissolution-Retarded Form And/Or Cyclodextrin In A Dissolution-Enhanced Form
|
US9120774B2
(en)
|
2004-11-03 |
2015-09-01 |
University Of Kansas |
Novobiocin analogues having modified sugar moieties
|
US20060105992A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Buchanan Charles M |
Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
|
KR101299821B1
(ko)
*
|
2004-12-07 |
2013-09-03 |
프로테올릭스, 인코퍼레이티드 |
프로테아좀 저해를 위한 조성물
|
US20060128654A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of cytidine analogs and derivatives
|
US20060128653A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of decitabine
|
US20060183725A1
(en)
*
|
2005-02-15 |
2006-08-17 |
Thomas Graeser |
Pharmaceutical preparation for oral contraception
|
AU2011204957B2
(en)
*
|
2005-10-26 |
2013-12-05 |
Cydex Pharmaceuticals, Inc |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
ES2364491T5
(es)
|
2005-10-26 |
2015-02-19 |
Cydex Pharmaceuticals, Inc. |
Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
|
US7629331B2
(en)
*
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
EP2623113B1
(de)
|
2005-11-09 |
2017-05-31 |
Onyx Therapeutics, Inc. |
Verbindung zur Enzymhemmung
|
US20070135586A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Shreyas Chakravarti |
Polyamide blend compositions formed article and process thereof
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
CA2634413A1
(en)
*
|
2005-12-20 |
2007-07-05 |
Tika Laekemedel Ab |
Method and system for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
WO2007095341A2
(en)
*
|
2006-02-15 |
2007-08-23 |
Tika Läkemedel Ab |
Sterilization of corticosteroids with reduced mass loss
|
US20080069889A1
(en)
*
|
2006-03-07 |
2008-03-20 |
Cherukuri S R |
Compressible resilient granules and formulations prepared therefrom
|
JP5226679B2
(ja)
|
2006-06-19 |
2013-07-03 |
プロテオリックス, インコーポレイテッド |
酵素阻害のための化合物
|
US8639782B2
(en)
|
2006-08-23 |
2014-01-28 |
Ebay, Inc. |
Method and system for sharing metadata between interfaces
|
US20090239942A1
(en)
*
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
US20080194519A1
(en)
*
|
2006-09-15 |
2008-08-14 |
Regents Of The University Of Minnesota |
Topiramate compositions and methods for their use
|
JP2010527285A
(ja)
*
|
2007-04-26 |
2010-08-12 |
シグモイド・ファーマ・リミテッド |
複数のミニカプセルの製造
|
US8343995B2
(en)
|
2007-04-27 |
2013-01-01 |
Cydex Pharmaceuticals, Inc. |
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
US7960353B2
(en)
*
|
2007-05-10 |
2011-06-14 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
US20110177161A1
(en)
*
|
2007-05-24 |
2011-07-21 |
Dr. Reddy's Laboratories Limited |
Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin
|
US20100184785A1
(en)
*
|
2007-06-06 |
2010-07-22 |
Basf Se |
Pharmaceutical formulation for the production of chewable tablets and lozenges
|
US10406105B2
(en)
*
|
2007-06-06 |
2019-09-10 |
Basf Se |
Pharmaceutical formulation for the production of rapidly disintegrating tablets
|
ES2493641T3
(es)
*
|
2007-06-28 |
2014-09-12 |
Cydex Pharmaceuticals, Inc. |
Administración nasal de soluciones acuosas de corticosteroides
|
TWI501773B
(zh)
|
2007-10-04 |
2015-10-01 |
Onyx Therapeutics Inc |
結晶肽環氧酮蛋白酶抑制劑以及胺基酸酮環氧化物之合成
|
CA2718416C
(en)
*
|
2008-03-13 |
2018-01-02 |
Mallinckrodt Inc. |
Multi-function, foot-activated controller for imaging system
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
WO2010014617A1
(en)
*
|
2008-07-28 |
2010-02-04 |
University Of Kansas |
Heat shock protein 90 inhibitor dosing methods
|
WO2010048298A1
(en)
|
2008-10-21 |
2010-04-29 |
Proteolix, Inc. |
Combination therapy with peptide epoxyketones
|
WO2010053487A1
(en)
|
2008-11-07 |
2010-05-14 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
MA32931B1
(fr)
|
2008-11-15 |
2012-01-02 |
Rib X Pharmaceuticals Inc |
Compositions antimicrobiennes
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
TWI504598B
(zh)
|
2009-03-20 |
2015-10-21 |
Onyx Therapeutics Inc |
結晶性三肽環氧酮蛋白酶抑制劑
|
EP2238973A1
(de)
|
2009-04-07 |
2010-10-13 |
Cephalon France |
Lyophilisierte Präparate von Proteasominhibitoren
|
US8236782B2
(en)
|
2009-05-13 |
2012-08-07 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
CN102458114A
(zh)
|
2009-05-29 |
2012-05-16 |
锡德克斯药物公司 |
包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
US8492538B1
(en)
|
2009-06-04 |
2013-07-23 |
Jose R. Matos |
Cyclodextrin derivative salts
|
WO2010147978A1
(en)
|
2009-06-16 |
2010-12-23 |
Pfizer Inc. |
Dosage forms of apixaban
|
WO2011041593A1
(en)
*
|
2009-09-30 |
2011-04-07 |
University Of Kansas |
Novobiocin analogues and treatment of polycystic kidney disease
|
EP2498793B1
(de)
|
2009-11-13 |
2019-07-10 |
Onyx Therapeutics, Inc. |
Oprozomib zur verwendung in der metastasensuppression
|
WO2011103150A2
(en)
|
2010-02-18 |
2011-08-25 |
Cephalon, Inc. |
Lyophilized preparations of bendamustine
|
US20130203721A1
(en)
|
2010-02-22 |
2013-08-08 |
Lupin Limited |
Taste-masked powder for suspension compositions of methylprednisolone
|
EP2542238B1
(de)
|
2010-03-01 |
2015-08-12 |
Onyx Therapeutics, Inc. |
Verbindungen zur immunproteasomhemmung
|
AU2011245630B2
(en)
|
2010-04-07 |
2014-07-03 |
Onyx Therapeutics, Inc. |
Crystalline peptide epoxyketone immunoproteasome inhibitor
|
EP2621475A1
(de)
|
2010-10-02 |
2013-08-07 |
Link Research&Grants Corporation |
Behandlung von tinnitus und zugehörigen dysfunktionen des gehörs
|
CA2816319C
(en)
|
2010-11-01 |
2020-06-30 |
Marshall Edwards, Inc. |
Isoflavonoid compounds and methods for the treatment of cancer
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
TWI544922B
(zh)
*
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠(olopatadine)眼用組成物
|
EP2758052B9
(de)
|
2011-09-18 |
2019-03-27 |
Euro-Celtique S.A. |
HDAC-Hemmer-Cyclopolysaccharidzusammensetzung
|
SG10201606063RA
(en)
|
2012-01-23 |
2016-09-29 |
Sage Therapeutics Inc |
Neuroactive steroid formulations and methods of treating cns disorders
|
AR092790A1
(es)
|
2012-02-01 |
2015-05-06 |
Euro Celtique Sa |
Derivados bencimidazolicos del acido hidroxamico
|
PT3702374T
(pt)
|
2012-02-15 |
2022-06-23 |
Cydex Pharmaceuticals Inc |
Processo de fabrico para derivados de ciclodextrina
|
JP2015508846A
(ja)
|
2012-02-28 |
2015-03-23 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法
|
WO2014011695A2
(en)
|
2012-07-09 |
2014-01-16 |
Onyx Therapeutics, Inc. |
Prodrugs of peptide epoxy ketone protease inhibitors
|
IL294306B2
(en)
|
2012-08-21 |
2024-01-01 |
Sage Therapeutics Inc |
Treatment methods for epilepsy and status epilepticus
|
AU2013334921B2
(en)
|
2012-10-22 |
2018-03-29 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
GB201312737D0
(en)
*
|
2013-07-17 |
2013-08-28 |
Univ Greenwich |
Cyclodextrin
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
GB201409488D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
GB201409485D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
NZ725354A
(en)
|
2014-06-18 |
2018-05-25 |
Elanco Us Inc |
Transdermal formulations of pergolide and uses thereof
|
FI3183295T3
(fi)
|
2014-08-22 |
2023-09-25 |
Cydex Pharmaceuticals Inc |
Fraktioidut alkyloidut syklodekstriinikoostumukset ja menetelmät niiden valmistamiseksi ja käyttämiseksi
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
CA2974123C
(en)
|
2015-02-02 |
2023-08-01 |
Mei Pharma, Inc. |
Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy
|
EP3939582A1
(de)
|
2015-03-19 |
2022-01-19 |
Cydex Pharmaceuticals, Inc. |
Zusammensetzungen mit silymarin und sulfoalkylethercyclodextrin und verfahren zur verwendung davon
|
US11266631B2
(en)
|
2016-10-11 |
2022-03-08 |
Purdue Pharmaceutical Products L.P. |
Hodgkin lymphoma therapy
|
CN110022857A
(zh)
|
2016-11-18 |
2019-07-16 |
艾库里斯抗感染治疗有限公司 |
基于改性环糊精和酸化剂的脒取代β-内酰胺化合物的新制剂、其制备及作为抗微生物药物组合物的用途
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
KR20190141244A
(ko)
|
2017-05-03 |
2019-12-23 |
사이덱스 파마슈티칼스, 인크. |
사이클로덱스트린 및 부설판을 함유하는 조성물
|
GB201709406D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro-Cletique S A |
Compounds for treating TNBC
|
GB201709405D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating ovarian cancer
|
GB201709402D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating t-pll
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
WO2019051477A1
(en)
|
2017-09-11 |
2019-03-14 |
Sage Therapeutics, Inc. |
METHODS OF TREATING EPILEPSY OR EPILEPTIC MALE CONDITION
|
CA3149914A1
(en)
|
2019-08-06 |
2021-02-11 |
L.E.A.F. Holdings Group Llc |
Processes of preparing polyglutamated antifolates and uses of their compositions
|
WO2021255291A1
(en)
|
2020-06-18 |
2021-12-23 |
The University Of Bristol |
Fatty acid complexes of coronavirus spike protein and their use
|
EP4243805A1
(de)
|
2020-08-07 |
2023-09-20 |
Gbiotech S.À.R.L. |
Kombinationstherapien zur behandlung von coronavirusinfektion
|
CN114128914B
(zh)
*
|
2021-12-02 |
2023-02-10 |
云南中烟工业有限责任公司 |
一种包合物、其制备方法及用途
|